FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Real-time Bid/Ask 09:50:54 24/05/2024 pm IST | ||
| 4.93 EUR / 4.95 EUR | -1.79% |
|
| Current month | -33.73% | ||
| 1 month | -80.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 4.96 | -1.39% |
| 23/24/23 | 5.03 | +22.68% |
| 22/24/22 | 4.1 | +23.12% |
| 21/24/21 | 3.33 | -1.48% |
| 20/24/20 | 3.38 | -3.15% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 09:24 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK4G0G |
| ISIN | DE000JK4G0G1 |
| Date issued | 22/03/2024 |
| Strike | 245.3 $ |
| Maturity | Unlimited |
| Parity | 5.27 : 1 |
| Emission price | 10.08 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 30.45 € |
|---|---|
| Lowest since issue | 2.88 € |
| Spread | 0.02 € |
| Spread % | 0.41% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
218.1
USD
Average target price
286.1
USD
Spread / Average Target
+31.18%
- Stock Market
- Certificates
- Certificat
